Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia.
Canan CelikerStefan ZelenakSamuel LietavaJiri PachernikMarketa BebarovaJana ZidkovaTomas NovotnyTomas BartaPublished in: Stem cell research (2024)
Human induced pluripotent stem cell (iPSC) lines were generated from peripheral blood mononuclear cells (PBMCs) isolated from two related patients diagnosed with either idiopathic ventricular fibrillation or catecholaminergic polymorphic ventricular tachycardia, carrying an unknown variant in the RYR2 gene, c.14201A>G (p.Y4734C) and one healthy related individual. Reprogramming was done using a commercially available Epi5 Reprogramming Kit. The pluripotency of the iPSC lines was verified by the expression of pluripotency markers and by their capacity to differentiate into all three embryonic germ layers in vitro. These iPSC lines are available for functional analysis and in vitro studies of RYR2 channelopathy.
Keyphrases
- induced pluripotent stem cells
- endothelial cells
- high glucose
- stem cells
- end stage renal disease
- heart failure
- diabetic rats
- drug induced
- left ventricular
- ejection fraction
- chronic kidney disease
- genome wide
- copy number
- newly diagnosed
- pluripotent stem cells
- peritoneal dialysis
- gene expression
- prognostic factors
- genome wide identification
- dna methylation
- cell therapy
- atrial fibrillation
- cell fate
- transcription factor
- stress induced